Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80062583
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
-
M-Fer Polysaccharide
;
M-Fer Polysaccharide 150 mg - Licence holder:
- Mantra Pharma Inc.
- Dosage Form:
- Capsule
- Recommended route of administration:
-
Oral
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adults | 1.0 | capsule | 1 | daily | ||||||||
- Recommended use or purpose:
- Helps to prevent iron deficiency anemia.
- Risk Information:
- Cautions and Warnings
- Keep out of reach of children. There is enough iron in this package to seriously harm a child. Do not use except under the care of a physician. Do not use for prolonged time unless instructed by physician. Consult a health care practitioner prior to use if you are pregnant or breastfeeding or if you have peptic ulcer, regional enteritis and ulcerative colitis. May cause abdominal cramping.
- Known Adverse Reactions
- Some people may experience constipation. Stop use if hypersensitivity occurs. Discontinue use and consult a healthcare practitioner if you experience symptoms of iron toxicity such as nausea, vomiting, abdominal pain, hematemesis (vomiting of blood), diarrhea or if you experience soreness or the presence of blood in the stool as this may aggravate existing peptic ulcer or other inflammatory conditions of the gastrointestinal tract. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
Iron |
150.0 mg
|
- List of non-medicinal ingredients:
-
- Colloidal silicon dioxide
- FD&C Blue No. 1
- FD&C Red No. 3
- FD&C Yellow No. 5
- Gelatin
- Magnesium stearate
- Microcrystalline cellulose
- Titanium dioxide
- Date of licensing:
- 2015-07-09
- Revised date of licence:
- 2023-08-25
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).